Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq

Hashim A. Hashim, Mohammed F. Maulood, Anwar M. Rasheed, Dhurgham F. Fatak, Khulood K. Kabah, Ahmed S. Abdulamir
doi: https://doi.org/10.1101/2020.10.26.20219345

Article Information

doi 
https://doi.org/10.1101/2020.10.26.20219345
History 
  • October 27, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Hashim A. Hashim1,
  2. Mohammed F. Maulood2,
  3. Anwar M. Rasheed3,
  4. Dhurgham F. Fatak3,
  5. Khulood K. Kabah3 and
  6. Ahmed S. Abdulamir4,*
  1. 1Alkarkh Hospital, Alatefiya, Baghdad, Iraq
  2. 2Alforat Hospital, Airport road, Baghdad, Iraq
  3. 3Alkharkh General Directorate of Health, Alkadymia, Baghdad, Iraq
  4. 4College of Medicine, Alnahrain University, Alkadymia, Baghdad, Iraq
  1. ↵*Corresponding author; email: ahmsah73{at}yahoo.com
Back to top
Posted October 27, 2020.
Download PDF
Data/Code
Email
Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq
Hashim A. Hashim, Mohammed F. Maulood, Anwar M. Rasheed, Dhurgham F. Fatak, Khulood K. Kabah, Ahmed S. Abdulamir
medRxiv 2020.10.26.20219345; doi: https://doi.org/10.1101/2020.10.26.20219345
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area